VERELAN PM Drug Patent Profile

✉ Email this page to a colleague

Which patents cover Verelan Pm, and when can generic versions of Verelan Pm launch?

Verelan Pm is a drug marketed by Azurity and is included in one NDA.

The generic ingredient in VERELAN PM is verapamil hydrochloride. There are seventeen drug master file entries for this compound. Forty-five suppliers are listed for this compound. Additional details are available on the verapamil hydrochloride profile page.

DrugPatentWatch^® Litigation and Generic Entry Outlook for Verelan Pm

A generic version of VERELAN PM was approved as verapamil hydrochloride by EXELA PHARMA on March 30^th, 1984.

Sign Up

AI Research Assistant

Questions you can ask:

What is the 5 year forecast for VERELAN PM?
What are the global sales for VERELAN PM?
What is Average Wholesale Price for VERELAN PM?

Summary for VERELAN PM

US Patents:	0
Applicants:	1
NDAs:	1
Finished Product Suppliers / Packagers:	2
Raw Ingredient (Bulk) Api Vendors:	78
Clinical Trials:	12
Patent Applications:	2,869
Drug Prices:	Drug price information for VERELAN PM
What excipients (inactive ingredients) are in VERELAN PM?	VERELAN PM excipients list
DailyMed Link:	VERELAN PM at DailyMed

Drug patent expirations by year for VERELAN PM

Recent Clinical Trials for VERELAN PM

Identify potential brand extensions & 505(b)(2) entrants

Sponsor	Phase
Assiut University	Early Phase 1
Theracos	Phase 1
National Cancer Institute (NCI)	Phase 1

See all VERELAN PM clinical trials

Pharmacology for VERELAN PM

Drug Class	Calcium Channel Blocker
Mechanism of Action	Calcium Channel Antagonists Cytochrome P450 3A Inhibitors Cytochrome P450 3A4 Inhibitors P-Glycoprotein Inhibitors

Paragraph IV (Patent) Challenges for VERELAN PM

Tradename	Dosage	Ingredient	Strength	NDA	ANDAs Submitted	Submissiondate
VERELAN PM	Extended-release Capsules	verapamil hydrochloride	100 mg and 200 mg	020943	1	2006-07-20
VERELAN PM	Extended-release Capsules	verapamil hydrochloride	300 mg	020943	1	2006-05-19

US Patents and Regulatory Information for VERELAN PM

+ Get email alerts for changes to this table

Glossary

Subscribe to access the full database, or Sign Up
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Azurity	VERELAN PM	verapamil hydrochloride	CAPSULE, EXTENDED RELEASE;ORAL	020943-001	Nov 25, 1998		RX	Yes	No	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
Azurity	VERELAN PM	verapamil hydrochloride	CAPSULE, EXTENDED RELEASE;ORAL	020943-002	Nov 25, 1998		RX	Yes	No	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
Azurity	VERELAN PM	verapamil hydrochloride	CAPSULE, EXTENDED RELEASE;ORAL	020943-003	Nov 25, 1998		RX	Yes	Yes	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

Expired US Patents for VERELAN PM

Subscribe to access the full database, or Sign Up
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	Patent No.	Patent Expiration
Azurity	VERELAN PM	verapamil hydrochloride	CAPSULE, EXTENDED RELEASE;ORAL	020943-001	Nov 25, 1998	⤷ Sign Up	⤷ Sign Up
Azurity	VERELAN PM	verapamil hydrochloride	CAPSULE, EXTENDED RELEASE;ORAL	020943-003	Nov 25, 1998	⤷ Sign Up	⤷ Sign Up
Azurity	VERELAN PM	verapamil hydrochloride	CAPSULE, EXTENDED RELEASE;ORAL	020943-002	Nov 25, 1998	⤷ Sign Up	⤷ Sign Up
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>Patent No.	>Patent Expiration

International Patents for VERELAN PM

See the table below for patents covering VERELAN PM around the world.

Subscribe to access the full database, or Sign Up
Country	Patent Number	Title	Estimated Expiration
Ireland	58401	Controlled absorption pharmaceutical composition	⤷ Sign Up
Greece	3003978		⤷ Sign Up
Spain	2039440		⤷ Sign Up
Australia	599385		⤷ Sign Up
Australia	7452887		⤷ Sign Up
Philippines	23993	CONTROLLED ABSORPTION PHARMACEUTICAL COMPOSITION	⤷ Sign Up
>Country	>Patent Number	>Title	>Estimated Expiration